The MYO15A gene plays a crucial role in the development and maintenance of the inner ear's structure, which is essential for proper hearing. Mutations in the MYO15A gene can lead to deafness, autosomal recessive type 3, a condition characterized by significant hearing loss from birth. This type of genetic hearing impairment is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
DNA Labs UAE offers a specialized genetic test to identify mutations in the MYO15A gene, providing crucial information for families affected by or at risk of autosomal recessive deafness type 3. The test involves analyzing the individual's DNA, extracted from a blood sample or cheek swab, to detect any alterations in the MYO15A gene that could lead to the condition.
The cost of the MYO15A gene deafness autosomal recessive type 3 genetic test at DNA Labs UAE is 4400 AED. This test is particularly valuable for prospective parents with a family history of the condition, individuals who have been diagnosed with unexplained hearing loss, and families seeking more information about their genetic health. By identifying the specific genetic cause of deafness, the test can facilitate informed decisions about family planning, early intervention, and management strategies for affected individuals.
The MYO3A Gene Deafness Autosomal Recessive Type 30 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the MYO3A gene that are linked to a form of hereditary hearing loss. This condition, known as Autosomal Recessive Deafness Type 30 (DFNB30), is characterized by the inheritance of two defective copies of the MYO3A gene, one from each parent, leading to early-onset hearing impairment. The test is crucial for families with a history of this condition, as it provides vital information for making informed decisions about management and intervention strategies.
Priced at 4400 AED, the test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of specific genetic mutations associated with DFNB30. The process is highly accurate and can pinpoint the genetic alterations responsible for the condition, offering insights into the likelihood of passing the mutation to future generations. Given the autosomal recessive inheritance pattern, understanding one's carrier status is particularly important for family planning purposes.
DNA Labs UAE, known for its state-of-the-art genetic testing services, ensures confidentiality and provides comprehensive support throughout the testing process. The results from this test not only aid in confirming a diagnosis but also play a critical role in guiding audiologists and other healthcare professionals in tailoring the most appropriate intervention and support for individuals affected by this form of genetic hearing loss.
The ESRRB Gene Deafness Autosomal Recessive Type 35 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the ESRRB gene that are responsible for Autosomal Recessive Deafness Type 35 (DFNB35). This condition is characterized by non-syndromic sensorineural hearing loss, which means it affects the inner ear or the nerve pathways to the brain without affecting other parts of the body. The test is crucial for families with a history of this condition, as it can provide definitive diagnosis, inform treatment decisions, and guide family planning.
Conducted through a sample of blood or saliva, the test specifically looks for alterations in the ESRRB gene, which plays a significant role in the development and maintenance of inner ear structures essential for hearing. Identifying a mutation can help in understanding the cause of deafness in an individual or family, facilitating early intervention and management strategies.
The cost of the ESRRB Gene Deafness Autosomal Recessive Type 35 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately detect and interpret genetic mutations associated with this form of hearing loss.
The "ESPN Gene Deafness Autosomal Recessive Type 36 Genetic Test" is a specific diagnostic tool designed to detect mutations in the ESPN gene, which can lead to autosomal recessive nonsyndromic deafness 36 (DFNB36). This condition is characterized by hearing loss that does not present with other symptoms. The test is crucial for early detection, allowing for timely intervention and management strategies to improve the quality of life for affected individuals.
Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, the test involves analyzing the patient's DNA to identify any alterations in the ESPN gene. These mutations disrupt the normal function of the protein produced by the gene, leading to the development of hearing loss.
The cost of the test is set at 4400 AED, reflecting the intricate process of genetic analysis and the specialized expertise required to interpret the results. By offering this test, DNA Labs UAE provides a vital resource for families with a history of hearing loss, enabling them to make informed decisions about their health and future.
The "HGF Gene Deafness Autosomal Recessive Type 39 Genetic Test" is a specialized diagnostic assessment designed to identify mutations in the HGF gene, which are linked to Autosomal Recessive Type 39 Deafness. This condition is a form of genetic hearing loss where an individual must inherit two copies of the altered gene, one from each parent, to be affected. The test is crucial for early detection and management of the condition, allowing for tailored interventions and support.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test provides a comprehensive analysis of the HGF gene to detect any abnormalities that could lead to hearing loss. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to accurately identify mutations in the gene. By opting for this test, individuals at risk can gain valuable insights into their genetic makeup, enabling informed decisions about their health and preventive measures to mitigate the impact of the condition.
The FOXI1 Gene Deafness Autosomal Recessive Type 4 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the FOXI1 gene, which are linked to a specific form of hereditary hearing loss. This type of hearing impairment, known as Autosomal Recessive Deafness Type 4, is passed down through families in a manner where both parents must carry a copy of the mutated gene to pass the condition onto their children. The test is crucial for early detection and management of the condition, allowing healthcare professionals to provide appropriate interventions and support to affected individuals.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab. The sample is then analyzed using advanced genetic sequencing technologies to identify any mutations in the FOXI1 gene that are associated with this type of deafness. The results can offer valuable information regarding the genetic predisposition of an individual to develop this condition, facilitating informed decisions about family planning and management strategies for those already affected.
The cost of the FOXI1 Gene Deafness Autosomal Recessive Type 4 Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive nature of the test, covering the expenses associated with the sophisticated technology and expertise required to accurately detect and interpret genetic mutations. For families and individuals facing the possibility of Autosomal Recessive Deafness Type 4, this test represents a critical step towards understanding and managing the condition effectively.
The ILDR1 gene deafness autosomal recessive type 42 genetic test is a specialized diagnostic tool used to identify mutations in the ILDR1 gene, which are linked to a form of genetic hearing loss known as autosomal recessive nonsyndromic deafness 42 (DFNB42). This condition is characterized by the absence of other clinical symptoms beyond hearing impairment, making genetic testing crucial for accurate diagnosis. The test is conducted through a comprehensive analysis of the patient's DNA to detect specific genetic alterations associated with DFNB42, providing essential information for early intervention and management strategies for affected individuals and their families.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability in results. The cost of the ILDR1 gene deafness autosomal recessive type 42 genetic test is set at 4400 AED, reflecting the intricate processes and sophisticated technology employed in identifying the genetic markers associated with this condition. Opting for this test at DNA Labs UAE not only offers a pathway to understanding the genetic basis of hearing loss in patients but also supports families in making informed decisions regarding health and future planning.
The MARVELD2 gene plays a crucial role in hearing processes, and mutations in this gene can lead to deafness autosomal recessive type 49 (DFNB49), a form of hereditary hearing loss. This condition is characterized by the absence or severe impairment of hearing from birth. Genetic testing for DFNB49 is essential for early diagnosis, which can significantly benefit from early interventions and management strategies for affected individuals.
DNA Labs UAE offers a specialized genetic test to detect mutations in the MARVELD2 gene associated with deafness autosomal recessive type 49. The test involves analyzing the individual's DNA to identify any genetic alterations that could lead to this specific type of hearing loss. This precise genetic testing is crucial for families with a history of hearing loss, providing them with valuable information regarding the risk and inheritance patterns of this condition.
The cost of the MARVELD2 gene deafness autosomal recessive type 49 genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to identify the genetic mutations responsible for this condition, offering families and individuals critical insights into managing and potentially mitigating the impacts of hereditary hearing loss.
The CCDC50 Gene Deafness Autosomal Dominant Type 44 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the CCDC50 gene, which are associated with Autosomal Dominant Non-Syndromic Hearing Loss (ADNSHL), specifically classified as Type 44. This condition is characterized by varying degrees of hearing impairment that can be present from birth or develop later in life, passed down through families in an autosomal dominant pattern. This means that just one copy of the altered gene in each cell is sufficient to cause the disorder.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. By analyzing a patient's DNA, the test can confirm a diagnosis of this type of hearing loss, predict its progression, and inform decisions regarding management and treatment. It is particularly useful for families with a history of hearing loss, providing crucial information for future planning and support.
The cost of the CCDC50 Gene Deafness Autosomal Dominant Type 44 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the technical process of isolating and examining the patient's DNA for the specific genetic mutations associated with the condition. Given the complex nature of genetic testing and the specialized knowledge required to interpret the results, the cost reflects both the technical and professional expertise provided by the laboratory. Patients considering this test are encouraged to discuss it with their healthcare provider to understand its benefits and implications fully.
The CEACAM16 Gene Deafness Autosomal Dominant Type 4B Genetic Test is a specialized diagnostic tool designed to identify mutations in the CEACAM16 gene, which are associated with Autosomal Dominant Non-Syndromic Hearing Loss (ADNSHL) type 4B. This condition is characterized by varying degrees of hearing impairment that can be passed down through families. The test is particularly crucial for individuals with a family history of hearing loss, as early detection can aid in timely intervention and management strategies to improve quality of life.
Performed at DNA Labs UAE, a leading facility in genetic testing, the process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed for specific genetic alterations in the CEACAM16 gene. The presence of these mutations can confirm the diagnosis of Autosomal Dominant Type 4B hearing loss, enabling healthcare providers to offer personalized care and counseling for affected individuals and their families.
The cost of the CEACAM16 Gene Deafness Autosomal Dominant Type 4B Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis and the detailed report provided by the lab, which includes actionable insights for managing the condition. It is a crucial step for those at risk, offering them an opportunity to understand their genetic makeup and take proactive measures towards hearing health.
